Sulforaphanes: disruptors of phagophores and autolysosomes

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Sulforaphane and its metabolites (SFNs) exhibit anti-cancer properties by inducing apoptosis.
• Understanding the precise mechanisms of SFN-induced cancer inhibition is crucial for developing effective anti-cancer drugs.

Purpose of the Study:

• To elucidate the molecular mechanisms by which SFNs inhibit cancer progression.
• To investigate the role of SFNs in microtubule dynamics, autophagy, and lipid metabolism.

Main Methods:

• Utilized high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) to analyze SFN's effects on protein expression and interactions.
• Investigated SFN's impact on microtubule stability, proteasome activity, and lysosomal fusion processes.
• Examined the regulation of fatty acid synthesis enzymes and mitophagy-related proteins.

Main Results:

• SFNs disrupt microtubules by activating the 26S proteasome, leading to protein degradation and depolymerization.
• SFNs inhibit the fusion of autophagosomes and mitophagosomes with lysosomes, causing their accumulation.
• SFNs downregulate key lipogenic enzymes (FASN, ACACA, ACLY) by activating the 26S proteasome and reducing fatty acid synthesis.
• SFNs decrease mitophagy-associated proteins (BNIP3L/NIX, BNIP3) and alter LC3-II/-I expression.

Conclusions:

• SFNs induce cancer cell apoptosis through a multi-pronged mechanism involving microtubule disruption and impaired autophagosome/mitophagosome clearance.
• SFN's inhibition of microtubule-associated lipoprotein activity and fatty acid synthesis contributes to its anti-cancer effects.
• SFN represents a promising therapeutic agent for cancer, targeting critical cellular processes like microtubule stability and organelle degradation.